QTC-4-MeOBnE Rescues Scopolamine-Induced Memory Deficits in Mice by Targeting Oxidative Stress, Neuronal Plasticity, and Apoptosis.
Alzheimer’s disease
acetylcholinesterase
apoptosis
glycogen synthase kinase
multitarget directed ligand
oxidative damage
Journal
ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337
Informations de publication
Date de publication:
06 05 2020
06 05 2020
Historique:
pubmed:
2
4
2020
medline:
22
6
2021
entrez:
2
4
2020
Statut:
ppublish
Résumé
Cognitive decline and memory impairment induced by disruption of cholinergic neurons and oxidative brain damage are among the earliest pathological hallmark signatures of Alzheimer's disease. Scopolamine is a postsynaptic muscarinic receptor blocker which causes impairment of cholinergic transmission resulting in cognitive deficits. Herein we investigated the effect of QTC-4-MeOBnE (1-(7-chloroquinolin-4-yl)-
Identifiants
pubmed: 32227985
doi: 10.1021/acschemneuro.9b00661
doi:
Substances chimiques
Scopolamine
DL48G20X8X
Acetylcholinesterase
EC 3.1.1.7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM